Cadila launches novel therapy for lung cancer Times of India Mycidac-C is an innovative research product for patients suffering from a cancer sub-type, non-small cell lung cancer, and will be priced at Rs 4,000 for 10 injections. The total cost of therapy to patients is estimated at Rs 40,000-- which the company ... |
